Mouse methylome studies SRP360183 Track Settings
 
Whole genome bisulfite sequencing of WT and Dnmt3a KO HSCs following chronic infection [murine Hematpoietic stem cell]

Track collection: Mouse methylome studies

+  All tracks in this collection (604)

Maximum display mode:       Reset to defaults   
Select views (Help):
AMR       CpG reads ▾       CpG methylation ▾       PMD       HMR      
Select subtracks by views and experiment:
 All views AMR  CpG reads  CpG methylation  PMD  HMR 
experiment
SRX14204996 
SRX14204997 
SRX14204998 
SRX14204999 
List subtracks: only selected/visible    all    ()
  experiment↓1 views↓2   Track Name↓3  
hide
 SRX14204996  AMR  murine Hematpoietic stem cell / SRX14204996 (AMR)   Schema 
hide
 SRX14204996  PMD  murine Hematpoietic stem cell / SRX14204996 (PMD)   Schema 
hide
 SRX14204996  HMR  murine Hematpoietic stem cell / SRX14204996 (HMR)   Schema 
hide
 Configure
 SRX14204996  CpG reads  murine Hematpoietic stem cell / SRX14204996 (CpG reads)   Schema 
hide
 Configure
 SRX14204996  CpG methylation  murine Hematpoietic stem cell / SRX14204996 (CpG methylation)   Schema 
hide
 SRX14204997  AMR  murine Hematpoietic stem cell / SRX14204997 (AMR)   Schema 
hide
 Configure
 SRX14204997  CpG reads  murine Hematpoietic stem cell / SRX14204997 (CpG reads)   Schema 
hide
 Configure
 SRX14204997  CpG methylation  murine Hematpoietic stem cell / SRX14204997 (CpG methylation)   Schema 
hide
 SRX14204997  PMD  murine Hematpoietic stem cell / SRX14204997 (PMD)   Schema 
hide
 SRX14204997  HMR  murine Hematpoietic stem cell / SRX14204997 (HMR)   Schema 
hide
 SRX14204998  AMR  murine Hematpoietic stem cell / SRX14204998 (AMR)   Schema 
hide
 Configure
 SRX14204998  CpG reads  murine Hematpoietic stem cell / SRX14204998 (CpG reads)   Schema 
hide
 Configure
 SRX14204998  CpG methylation  murine Hematpoietic stem cell / SRX14204998 (CpG methylation)   Schema 
hide
 SRX14204998  PMD  murine Hematpoietic stem cell / SRX14204998 (PMD)   Schema 
hide
 SRX14204998  HMR  murine Hematpoietic stem cell / SRX14204998 (HMR)   Schema 
hide
 SRX14204999  HMR  murine Hematpoietic stem cell / SRX14204999 (HMR)   Schema 
hide
 SRX14204999  AMR  murine Hematpoietic stem cell / SRX14204999 (AMR)   Schema 
hide
 Configure
 SRX14204999  CpG reads  murine Hematpoietic stem cell / SRX14204999 (CpG reads)   Schema 
hide
 Configure
 SRX14204999  CpG methylation  murine Hematpoietic stem cell / SRX14204999 (CpG methylation)   Schema 
hide
 SRX14204999  PMD  murine Hematpoietic stem cell / SRX14204999 (PMD)   Schema 
    

Study title: Whole genome bisulfite sequencing of WT and Dnmt3a KO HSCs following chronic infection
SRA: SRP360183
GEO: not found
Pubmed: not found

Experiment Label Methylation Coverage HMRs HMR size AMRs AMR size PMDs PMD size Conversion Details
SRX14204996 murine Hematpoietic stem cell 0.794 11.6 51387 953.9 276 1063.5 3396 6977.0 0.998 title: GSM5904385 WT naïve, Mus musculus, Bisulfite-Seq; {"source_name": "Hematopoietic stem cells LK CD150+ CD48-", "cell_type": "murine Hematpoietic stem cells", "treatment": "nave", "genotype": "WT"}
SRX14204997 murine Hematpoietic stem cell 0.785 13.8 58282 919.4 322 1093.5 3838 8281.2 0.998 title: GSM5904386 WT infected, Mus musculus, Bisulfite-Seq; {"source_name": "Hematopoietic stem cells LK CD150+ CD48-", "cell_type": "murine Hematpoietic stem cells", "treatment": "1 month M. avium infection", "genotype": "WT"}
SRX14204998 murine Hematpoietic stem cell 0.755 19.1 66743 919.0 693 903.8 3826 9003.1 0.980 title: GSM5904387 Dnmt3a KO naïve, Mus musculus, Bisulfite-Seq; {"source_name": "Hematopoietic stem cells LK CD150+ CD48-", "cell_type": "murine Hematpoietic stem cells", "treatment": "nave", "genotype": "Dnmt3a KO"}
SRX14204999 murine Hematpoietic stem cell 0.768 20.0 76443 1005.8 673 885.3 4899 11148.2 0.980 title: GSM5904388 Dnmt3a KO infected, Mus musculus, Bisulfite-Seq; {"source_name": "Hematopoietic stem cells LK CD150+ CD48-", "cell_type": "murine Hematpoietic stem cells", "treatment": "1 month M. avium infection", "genotype": "Dnmt3a KO"}

Methods

All analysis was done using a bisulfite sequnecing data analysis pipeline DNMTools developed in the Smith lab at USC.

Mapping reads from bisulfite sequencing: Bisulfite treated reads are mapped to the genomes with the abismal program. Input reads are filtered by their quality, and adapter sequences in the 3' end of reads are trimmed. This is done with cutadapt. Uniquely mapped reads with mismatches/indels below given threshold are retained. For pair-end reads, if the two mates overlap, the overlapping part of the mate with lower quality is discarded. After mapping, we use the format command in dnmtools to merge mates for paired-end reads. We use the dnmtools uniq command to randomly select one from multiple reads mapped exactly to the same location. Without random oligos as UMIs, this is our best indication of PCR duplicates.

Estimating methylation levels: After reads are mapped and filtered, the dnmtools counts command is used to obtain read coverage and estimate methylation levels at individual cytosine sites. We count the number of methylated reads (those containing a C) and the number of unmethylated reads (those containing a T) at each nucleotide in a mapped read that corresponds to a cytosine in the reference genome. The methylation level of that cytosine is estimated as the ratio of methylated to total reads covering that cytosine. For cytosines in the symmetric CpG sequence context, reads from the both strands are collapsed to give a single estimate. Very rarely do the levels differ between strands (typically only if there has been a substitution, as in a somatic mutation), and this approach gives a better estimate.

Bisulfite conversion rate: The bisulfite conversion rate for an experiment is estimated with the dnmtools bsrate command, which computes the fraction of successfully converted nucleotides in reads (those read out as Ts) among all nucleotides in the reads mapped that map over cytosines in the reference genome. This is done either using a spike-in (e.g., lambda), the mitochondrial DNA, or the nuclear genome. In the latter case, only non-CpG sites are used. While this latter approach can be impacted by non-CpG cytosine methylation, in practice it never amounts to much.

Identifying hypomethylated regions (HMRs): In most mammalian cells, the majority of the genome has high methylation, and regions of low methylation are typically the interesting features. (This seems to be true for essentially all healthy differentiated cell types, but not cells of very early embryogenesis, various germ cells and precursors, and placental lineage cells.) These are valleys of low methylation are called hypomethylated regions (HMR) for historical reasons. To identify the HMRs, we use the dnmtools hmr command, which uses a statistical model that accounts for both the methylation level fluctations and the varying amounts of data available at each CpG site.

Partially methylated domains: Partially methylated domains are large genomic regions showing partial methylation observed in immortalized cell lines and cancerous cells. The pmd program is used to identify PMDs.

Allele-specific methylation: Allele-Specific methylated regions refers to regions where the parental allele is differentially methylated compared to the maternal allele. The program allelic is used to compute allele-specific methylation score can be computed for each CpG site by testing the linkage between methylation status of adjacent reads, and the program amrfinder is used to identify regions with allele-specific methylation.

For more detailed description of the methods of each step, please refer to the DNMTools documentation.